Actively Recruiting
Comparative Outcomes of Four Versus Two Balloon Inflation Points in Dacryoplasty for Primary Acquired Nasolacrimal Duct Obstruction
Led by National Taiwan University Hospital · Updated on 2025-11-06
50
Participants Needed
1
Research Sites
134 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Primary acquired nasolacrimal duct obstruction
CONDITIONS
Official Title
Comparative Outcomes of Four Versus Two Balloon Inflation Points in Dacryoplasty for Primary Acquired Nasolacrimal Duct Obstruction
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients diagnosed with primary acquired nasolacrimal duct obstruction (PANDO)
You will not qualify if you...
- Patients who are pregnant
- Patients with previous lacrimal procedure
- Patients with upper lacrimal drainage obstruction
- Patients with punctal stenosis
- Patients with active dacryocystitis
- Patients with dacryolithiasis
- Patients with traumatic obstruction
- Patients with lacrimal mass
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
National Taiwan University Hospital
Taipei, Taiwan
Actively Recruiting
Research Team
Y
Yi-Hsuan Wei, PhD
CONTACT
M
Meng-Ju Lin, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here